Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Nanovibronix Inc (NAOV)

Nanovibronix Inc (NAOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
NanoVibronix Issues Letter to Shareholders

NanoVibronix, Inc ., (NASDAQ: NAOV), a medical device company that produces the UroShield ® , PainShield ® and WoundShield ® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today...

NAOV : 0.7061 (+8.63%)
NanoVibronix Receives Positive Final Results of Independent Lifecycle Testing of PainShield Prompted by Centers for Medicare and Medicaid Services (CMS)

NanoVibronix, Inc ., (NASDAQ: NAOV) (the “Company”), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (“SAW”) technology, today announced...

NAOV : 0.7061 (+8.63%)
NanoVibronix Files Provisional U.S. Patent Application for UroShield Ultra

NanoVibronix, Inc ., (NASDAQ: NAOV) (the “Company”), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (“SAW”) technology, today announced...

NAOV : 0.7061 (+8.63%)
NanoVibronix Announces Positive Results from Independent Product Trial of UroShield for Patients with a Spinal Cord Injury

NanoVibronix, Inc. , (NASDAQ: NAOV) (the “Company”), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced...

NAOV : 0.7061 (+8.63%)
NanoVibronix Regains Nasdaq Compliance

NanoVibronix, Inc . (NASDAQ: NAOV) (the “Company”), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today...

NAOV : 0.7061 (+8.63%)
NanoVibronix to Launch Rental Program for PainShield and UroShield

NanoVibronix, Inc ., (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that it intends to launch...

NAOV : 0.7061 (+8.63%)
NanoVibronix Announces Reverse Stock Split

NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company”), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that...

NAOV : 0.7061 (+8.63%)
NanoVibronix Provides Update on Expanding Access to PainShield

NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company”), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today provided an...

NAOV : 0.7061 (+8.63%)
NanoVibronix Announces Results of Annual Meeting of Stockholders Held Today

NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company”), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, announced that the...

NAOV : 0.7061 (+8.63%)
NanoVibronix Announces Partnership with Peak Medical, Ltd.

NanoVibronix, Inc . (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that it has partnered...

NAOV : 0.7061 (+8.63%)

Barchart Exclusives

NVDA Stock Looks Cheap to Value Buyers Based on its Huge FCF Margins
Nvidia reported strong Q3 free cash flow margins and analysts have raised their revenue forecasts. This means NVDA stock could be undervalued by 26% with a price target of $179 per share. Shorting OTM puts is attracting interest. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar